3. Amneal Announces U.S. FDA Filing Acceptance of Abbreviated New Drug Application for Naloxone Hydrochloride Nasal Spray, USP, 4mg. News Release. Amneal Pharmaceuticals. March 2, 2023. Accessed April 25, 2024. https://investors.amneal.com/news/press-releases/press-release-details/2023/Amneal-Announces-U.S.-FDA-Filing-Acceptance-of-Abbreviated-New-Drug-Application-for-Naloxone-Hydrochloride-Nasal-Spray-USP-4mg/default.aspx